ORAMED PHARMACEUTICALS INC. Financing Cash Flow
ORAMED PHARMACEUTICALS INC. (ORMP) reported Financing Cash Flow of -$12.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$1.95M.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$10.36M.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$4.01M.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$361.00K.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2025 was -$4.74M.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2024 was -$52.04M, a 200.11% decline from fiscal 2023.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2023 was $51.98M, a 382.22% increase from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2022 was $10.78M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 4 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 116 month | Net Cash Provided by (Used in) Financing Activities 119 month | Net Cash Provided by (Used in) Financing Activities 122 month | Net Cash Provided by (Used in) Financing Activities 125 month | Net Cash Provided by (Used in) Financing Activities 128 month | Net Cash Provided by (Used in) Financing Activities 131 month | Net Cash Provided by (Used in) Financing Activities 134 month | Net Cash Provided by (Used in) Financing Activities 137 month | Net Cash Provided by (Used in) Financing Activities 140 month | Net Cash Provided by (Used in) Financing Activities 143 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.31M 10-Q · filed 2026-08-10 | -$16.32M derived: sum of 3 quarters · filed 2026-08-10 | -$16.68M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2026-03-31 | -$10.36M 10-Q · filed 2026-05-19 | -$14.37M derived: sum of 2 quarters · filed 2026-05-19 | -$14.73M derived: sum of 3 quarters · filed 2026-05-19 | |||||||||||||||
| 2025-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$4.37M derived: sum of 2 quarters · filed 2026-03-26 | -$4.74M 10-K · filed 2026-03-26 | |||||||||||||||
| 2025-09-30 | -$361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$732.00K 10-Q · filed 2025-11-13 | ||||||||||||||||
| 2025-06-30 | -$371.00K 10-Q · filed 2026-08-10 | |||||||||||||||||
| 2024-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$2.49M derived: sum of 2 quarters · filed 2026-03-26 | -$33.04M derived: sum of 3 quarters · filed 2026-03-26 | -$52.04M 10-K · filed 2026-03-26 | ||||||||||||||
| 2024-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$31.84M derived: sum of 2 quarters · filed 2025-11-13 | -$50.84M 10-Q · filed 2025-11-13 | -$75.84M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||
| 2024-06-30 | -$30.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$49.55M 10-Q · filed 2025-08-14 | -$74.55M derived: sum of 3 quarters · filed 2025-08-14 | -$2.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||
| 2024-03-31 | -$19.00M 10-Q · filed 2025-05-15 | -$44.00M derived: sum of 2 quarters · filed 2025-05-15 | $30.55M derived: sum of 3 quarters · filed 2025-05-15 | $30.55M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||
| 2023-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $49.55M derived: sum of 2 quarters · filed 2025-03-27 | $49.55M derived: sum of 3 quarters · filed 2025-03-27 | $51.98M 10-K · filed 2025-03-27 | ||||||||||||||
| 2023-09-30 | $74.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $74.55M derived: sum of 2 quarters · filed 2024-11-07 | $76.98M 10-Q · filed 2024-11-07 | $81.15M derived: sum of 4 quarters · filed 2024-11-07 | ||||||||||||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.43M 10-Q · filed 2024-08-14 | $6.61M derived: sum of 3 quarters · filed 2024-08-14 | $10.92M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||
| 2023-03-31 | $2.43M 10-Q · filed 2024-05-09 | $6.61M derived: sum of 2 quarters · filed 2024-05-09 | $10.92M derived: sum of 3 quarters · filed 2024-05-09 | $10.92M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||||||
| 2022-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $8.49M derived: sum of 2 quarters · filed 2024-03-06 | $8.49M derived: sum of 3 quarters · filed 2024-03-06 | $10.78M 10-K · filed 2024-03-06 | ||||||||||||||
| 2022-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.31M derived: sum of 2 quarters · filed 2023-11-09 | $6.60M 10-Q · filed 2023-11-09 | |||||||||||||||
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.29M 10-Q · filed 2023-08-10 | ||||||||||||||||
| 2022-03-31 | $2.29M 10-Q · filed 2023-05-11 | |||||||||||||||||
| 2021-12-31 | $60.57M 10-K · filed 2023-03-06 | |||||||||||||||||
| 2021-11-30 | $60.56M 10-Q · filed 2022-01-11 | |||||||||||||||||
| 2021-09-30 | $40.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $97.74M 10-Q · filed 2022-11-10 | ||||||||||||||||
| 2021-08-31 | $55.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $102.89M 10-K · filed 2023-03-06 | ||||||||||||||||
| 2021-06-30 | $28.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $57.55M 10-Q · filed 2022-08-10 | ||||||||||||||||
| 2021-05-31 | $21.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-14 | $47.87M 10-Q · filed 2021-07-14 | ||||||||||||||||
| 2021-03-31 | $29.03M 10-Q · filed 2022-05-12 | |||||||||||||||||
| 2021-02-28 | $25.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $26.01M 10-Q · filed 2021-04-13 | $27.49M derived: sum of 3 quarters · filed 2022-01-11 | $47.47M derived: sum of 4 quarters · filed 2022-01-11 | ||||||||||||||
| 2020-12-31 | $13.00M 10-QT · filed 2022-03-30 | |||||||||||||||||
| 2020-11-30 | $586.00K 10-Q · filed 2022-01-11 | $2.06M derived: sum of 2 quarters · filed 2022-01-11 | $22.04M derived: sum of 3 quarters · filed 2022-01-11 | $24.36M derived: sum of 4 quarters · filed 2022-01-11 | ||||||||||||||
| 2020-08-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $21.46M derived: sum of 2 quarters · filed 2021-11-24 | $23.77M derived: sum of 3 quarters · filed 2021-11-24 | $23.79M 10-K · filed 2021-11-24 | ||||||||||||||
| 2020-05-31 | $19.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-14 | $22.30M derived: sum of 2 quarters · filed 2021-07-14 | $22.31M 10-Q · filed 2021-07-14 | |||||||||||||||
| 2020-02-29 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $2.33M 10-Q · filed 2021-04-13 | ||||||||||||||||
| 2019-11-30 | $13.00K 10-Q · filed 2021-01-14 | |||||||||||||||||
| 2018-08-31 | $16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $16.78M derived: sum of 2 quarters · filed 2019-11-27 | $17.49M derived: sum of 3 quarters · filed 2019-11-27 | $22.65M 10-K · filed 2019-11-27 | ||||||||||||||
| 2018-05-31 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-10 | $1.00M derived: sum of 2 quarters · filed 2019-07-10 | $6.16M 10-Q · filed 2019-07-10 | $7.43M derived: sum of 4 quarters · filed 2019-11-27 | ||||||||||||||
| 2018-02-28 | $718.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-10 | $5.88M 10-Q · filed 2019-04-10 | $7.14M derived: sum of 3 quarters · filed 2019-11-27 | $7.14M derived: sum of 4 quarters · filed 2019-11-27 | ||||||||||||||
| 2017-11-30 | $5.16M 10-Q · filed 2019-01-14 | $6.43M derived: sum of 2 quarters · filed 2019-11-27 | $6.43M derived: sum of 3 quarters · filed 2019-11-27 | $6.43M derived: sum of 4 quarters · filed 2019-11-27 | ||||||||||||||
| 2017-08-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.27M derived: sum of 2 quarters · filed 2019-11-27 | $1.27M derived: sum of 3 quarters · filed 2019-11-27 | $1.59M 10-K · filed 2019-11-27 | ||||||||||||||
| 2017-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-12 | $0.00 derived: sum of 2 quarters · filed 2018-07-12 | $320.00K 10-Q · filed 2018-07-12 | $431.00K derived: sum of 4 quarters · filed 2018-11-28 | ||||||||||||||
| 2017-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-09 | $320.00K 10-Q · filed 2018-04-09 | $431.00K derived: sum of 3 quarters · filed 2018-11-28 | $483.00K derived: sum of 4 quarters · filed 2018-11-28 | ||||||||||||||
| 2016-11-30 | $320.00K 10-Q · filed 2018-01-11 | $431.00K derived: sum of 2 quarters · filed 2018-11-28 | $483.00K derived: sum of 3 quarters · filed 2018-11-28 | $12.20M derived: sum of 4 quarters · filed 2018-11-28 | ||||||||||||||
| 2016-08-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-28 | $163.00K derived: sum of 2 quarters · filed 2018-11-28 | $11.88M derived: sum of 3 quarters · filed 2018-11-28 | $12.04M 10-K · filed 2018-11-28 | ||||||||||||||
| 2016-05-31 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-06 | $11.77M derived: sum of 2 quarters · filed 2017-07-06 | $11.93M 10-Q · filed 2017-07-06 | $16.81M derived: sum of 4 quarters · filed 2017-11-29 | ||||||||||||||
| 2016-02-29 | $11.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-05 | $11.88M 10-Q · filed 2017-04-05 | $16.76M derived: sum of 3 quarters · filed 2017-11-29 | $16.76M derived: sum of 4 quarters · filed 2017-11-29 | ||||||||||||||
| 2015-11-30 | $164.00K 10-Q · filed 2017-01-11 | $5.04M derived: sum of 2 quarters · filed 2017-11-29 | $5.04M derived: sum of 3 quarters · filed 2017-11-29 | $5.05M derived: sum of 4 quarters · filed 2017-11-29 | ||||||||||||||
| 2015-08-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $4.88M derived: sum of 2 quarters · filed 2017-11-29 | $4.89M derived: sum of 3 quarters · filed 2017-11-29 | $9.72M 10-K · filed 2017-11-29 | ||||||||||||||
| 2015-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-07-06 | $8.00K derived: sum of 2 quarters · filed 2016-07-06 | $4.84M 10-Q · filed 2016-07-06 | $4.84M derived: sum of 4 quarters · filed 2016-11-25 | ||||||||||||||
| 2015-02-28 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-06 | $4.84M 10-Q · filed 2016-04-06 | $4.84M derived: sum of 3 quarters · filed 2016-11-25 | $4.99M derived: sum of 4 quarters · filed 2016-11-25 | ||||||||||||||
| 2014-11-30 | $4.83M 10-Q · filed 2016-01-13 | $4.83M derived: sum of 2 quarters · filed 2016-11-25 | $4.98M derived: sum of 3 quarters · filed 2016-11-25 | |||||||||||||||
| 2014-08-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-25 | $145.00K derived: sum of 2 quarters · filed 2016-11-25 | $16.64M 10-K · filed 2016-11-25 | |||||||||||||||
| 2014-05-31 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-01 | $16.64M 10-Q · filed 2015-07-01 | $16.64M 10-Q · filed 2014-07-14 | |||||||||||||||
| 2014-02-28 | $16.50M 10-Q · filed 2015-04-03 | $16.49M 10-Q · filed 2014-04-10 | $37.81M 10-Q · filed 2014-04-10 | |||||||||||||||
| 2013-11-30 | $21.32M 10-Q · filed 2014-01-14 | |||||||||||||||||
| 2013-08-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | $4.37M derived: sum of 2 quarters · filed 2015-11-25 | $4.37M derived: sum of 3 quarters · filed 2015-11-25 | $5.82M 10-K · filed 2015-11-25 | $5.82M 10-K · filed 2013-11-27 | $21.32M 10-K · filed 2013-11-27 | ||||||||||||
| 2013-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-14 | -$7.50K derived: sum of 2 quarters · filed 2014-07-14 | $1.45M 10-Q · filed 2014-07-14 | $16.94M 10-Q · filed 2013-07-17 | ||||||||||||||
| 2013-02-28 | -$7.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-10 | $1.45M 10-Q · filed 2014-04-10 | $16.94M 10-Q · filed 2013-04-11 | |||||||||||||||
| 2012-11-30 | $1.46M 10-Q · filed 2014-01-14 | $16.95M 10-Q · filed 2012-12-26 | ||||||||||||||||
| 2012-08-31 | $3.49M 10-K · filed 2014-11-14 | $3.49M 10-K · filed 2012-12-12 | $15.49M 10-K · filed 2012-12-12 | |||||||||||||||
| 2012-05-31 | $12.00M 10-Q · filed 2012-07-12 | |||||||||||||||||
| 2012-02-29 | $12.00M 10-Q · filed 2012-04-04 | |||||||||||||||||
| 2011-11-30 | $12.00M 10-Q · filed 2012-01-12 | |||||||||||||||||
| 2011-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-12 | $588.21K derived: sum of 2 quarters · filed 2012-12-12 | $3.39M derived: sum of 3 quarters · filed 2012-12-12 | $3.69M 10-K · filed 2012-12-12 | ||||||||||||||
| 2011-05-31 | $588.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-12 | $3.39M derived: sum of 2 quarters · filed 2012-07-12 | $3.69M 10-Q · filed 2012-07-12 | |||||||||||||||
| 2011-02-28 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-04 | $3.11M 10-Q · filed 2012-04-04 | ||||||||||||||||
| 2010-11-30 | $300.00K 10-Q · filed 2012-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |